Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
GlioblastomaAnaplastic AstrocytomaAstrocytomaAnaplastic Oligodendroglioma
Interventions
OTHER

Adaptive Radiotherapy

"Each patient will undergo a brain MRI at the following time points:~1. Baseline- within 2 weeks prior to the start of chemo-RT,~2. Week #1- on Fractions # 4 or 5~3. Week #2- between Fractions # 6-10 (at least 5 days after the Week 1 MRI)~4. Week #3- between Fractions # 11-15 (at least 5 days after the Week 2 MRI)~5. Week #4- between Fractions # 16-20 gadolinium contrast (at least 5 days after the Week 3 MRI)~6. Week #5- on Fractions # 24 or 25 (after the start of the Conedown)~7. Week #6- +/- 3 days of Fraction #30 (end of RT)~Patients receiving hypofractionated radiotherapy will undergo a brain MRI at the following time points:~1. Baseline- within 2 weeks prior to the start of your standard of care chemotherapy radiation treatment (chemo-RT),~2. Week #1 - on Fractions #4 or 5~3. Week #2 - between Fractions #6-10 (at least 5 days after the Week 1 MRI)~4. Week #3 - between Fractions #11-15 (at least 5 days after the Week 2 MRI)"

Trial Locations (1)

10032

RECRUITING

Columbia University Irving Medical Center/NYPH, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

Columbia University

OTHER